Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald
Start price
06.06.25
/
50%
€22.79
Target price
06.06.26
-
Performance (%)
-10.27%
Price
22:26
€20.45
Summary
This prediction is currently active. The price of Catalyst Pharmaceutical Partners Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.27%. This prediction currently runs until 06.06.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 6.240% | 6.240% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.55
22.03.24
22.03.24
€31.46
22.03.25
22.03.25
64.12%
23.03.25
23.03.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.00
01.03.24
01.03.24
€31.37
01.03.25
01.03.25
39.63%
02.03.25
02.03.25